GLP-1 Medications: Beyond Weight Loss
- August 22, 2026
- Lifestyle
GLP-1 medications are a class of medicines that mimic the effects of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which is released by the gut after eating.
GLP-1 plays an important role in regulating blood glucose and appetite. It signals the pancreas to release insulin when blood glucose is elevated, reduces the release of glucagon, slows stomach emptying, and sends signals to the brain that contribute to feelings of fullness.
Medications that act on this pathway, such as semaglutide and liraglutide, were initially developed primarily for the treatment of type 2 diabetes. Some are now also approved for chronic weight management in people who meet specific clinical criteria.
Their popularity has largely been driven by their ability to support significant weight loss, but their effects extend beyond the number on the scales.
The growing research around these medications has shifted the conversation from weight loss alone towards metabolic and overall health.
Last updated: July 04, 2026
Table of Contents
This article is for educational purposes only and is not a substitute for professional medical advice.
Beyond Weight Loss: Metabolic and Cardiovascular Health
One of the most important reasons GLP-1 medications are being studied beyond weight loss is their effect on metabolic and cardiovascular health.
In people with type 2 diabetes, GLP-1 receptor agonists can improve blood glucose control by increasing insulin secretion when glucose levels are elevated and reducing glucagon release. This can help lower blood glucose and HbA1c levels. Their effects on appetite and body weight can also improve several metabolic risk factors.
The cardiovascular benefits have attracted particular attention. In the SELECT trial, which included adults with overweight or obesity, established cardiovascular disease, and no diabetes, semaglutide reduced the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke, by 20% compared with placebo.
These findings are important because they suggest that the benefits of some GLP-1 medications may extend beyond changes in body weight. However, cardiovascular benefits are drug- and patient-specific, and GLP-1 medications should not be viewed as a universal preventative treatment for everyone.
The broader picture is that GLP-1 medications can influence several interconnected aspects of health, including blood glucose, appetite, body weight, and cardiovascular risk.
How Do GLP-1 Medications Affect Appetite and Metabolism?
GLP-1 medications work on several pathways involved in appetite and energy regulation.
One of their effects is slowing gastric emptying, meaning food can move more slowly from the stomach into the small intestine. This can contribute to feeling fuller for longer after eating.
They also act on areas of the brain involved in appetite regulation. By increasing feelings of satiety and reducing hunger, they can make it easier for some people to consume less food without experiencing the same level of hunger.
At the same time, GLP-1 receptor agonists influence glucose regulation. They stimulate insulin release when blood glucose is elevated and suppress glucagon secretion, helping the body maintain more stable blood glucose levels.
These effects work together rather than acting independently. The medication is not simply “burning fat”; it changes several physiological signals involved in appetite, digestion, and glucose metabolism.
This is also why stopping treatment can lead to increased appetite and weight regain in some people. GLP-1 medications are generally considered part of a longer-term medical approach rather than a quick fix.
Side Effects and Safety
GLP-1 medications can be highly effective, but like any prescription medication, they are not completely free of risks.
The most common side effects are gastrointestinal, particularly nausea, vomiting, diarrhoea, constipation, and abdominal discomfort. These symptoms are often more noticeable when treatment is first started or when the dose is increased.
More serious complications are less common but can occur. These include pancreatitis, gallbladder disease, severe gastrointestinal reactions, and dehydration-related kidney injury. People taking these medications should therefore be monitored appropriately, particularly if they experience persistent vomiting or diarrhoea.
GLP-1 medications are also not suitable for everyone. For example, semaglutide products are contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
Importantly, these medications should be prescribed and monitored by a healthcare professional. The growing popularity of compounded or unapproved GLP-1 products has also raised concerns about dosing errors and adverse events, making the source and supervision of treatment particularly important.
Other Potential Health Benefits
GLP-1 medications are being studied for benefits that go beyond weight loss and blood sugar control.
Research has shown that some GLP-1 medications can reduce the risk of certain cardiovascular problems, particularly in people with type 2 diabetes or existing cardiovascular disease. Some medications in this class have also shown benefits for people with certain kidney conditions.
There is also growing interest in their effects on liver health. Fat can build up in the liver as part of a condition known as metabolic dysfunction-associated steatotic liver disease (MASLD). Some GLP-1-based treatments may help improve this condition, particularly when weight loss and improved metabolic health occur alongside treatment.
Researchers are also investigating whether GLP-1 medications could have benefits in other areas of health. However, many of these potential uses are still being studied, so they should not yet be considered proven treatments.
The important point is that GLP-1 medications may influence several aspects of health—not simply weight and appetite, but also blood sugar, heart health, kidney health, and potentially liver health.
Who Are GLP-1 Medications For?
GLP-1 medications are prescription medicines, not general wellness or weight-loss products. Whether someone is suitable for treatment depends on their medical history, health goals, current medications, and individual risk factors.
For weight management, these medications are generally prescribed to people who meet specific clinical criteria, such as having obesity or being overweight alongside a weight-related health condition. They are typically used alongside changes in diet and physical activity rather than as a replacement for them.
They can also be prescribed for people with type 2 diabetes, where certain GLP-1 medications help improve blood glucose control. Some products have additional approved uses, including reducing cardiovascular risk in specific groups.
Importantly, GLP-1 medications are not suitable for everyone. Certain medical conditions, medications, pregnancy, and personal or family medical history can affect whether they are appropriate. For example, semaglutide should not be used by people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
This is why these medications should be prescribed and monitored by a qualified healthcare professional rather than used based solely on social-media trends or recommendations from friends.
What Happens When You Stop Taking GLP-1 Medications?
One important question is what happens after someone stops treatment. GLP-1 medications are not necessarily a short-term solution, particularly when they are being used to manage obesity, which is considered a chronic condition.
Research has found that weight regain is common after stopping treatment. In the STEP 1 extension study, people who stopped semaglutide after 68 weeks regained around two-thirds of the weight they had previously lost over the following year. Some of the improvements in metabolic health also moved back towards their starting levels.
This does not mean that stopping the medication is always wrong. Treatment decisions should be individualised and made with a healthcare professional. However, it highlights an important point: GLP-1 medications are not simply a quick fix.
For some people, long-term treatment may be needed to maintain the benefits, alongside nutrition, physical activity, and other lifestyle approaches.
Important Considerations for Women
For women of reproductive age, GLP-1 medications require particular consideration around pregnancy and contraception.
These medications are not recommended for weight loss during pregnancy, and semaglutide may remain in the body for an extended period. Current prescribing information advises stopping semaglutide at least two months before a planned pregnancy.
This is particularly important because pregnancy can change the way medications should be used, and intentional weight loss is not recommended during pregnancy.
Anyone who is pregnant, planning a pregnancy, or breastfeeding should therefore discuss their medication with their healthcare professional rather than stopping or continuing treatment independently.
For women taking GLP-1 medications, reproductive planning should be considered as part of the overall treatment plan, not as an afterthought.
Final Thoughts
FAQ
- Are GLP-1 medications only for weight loss?
No. GLP-1 medications are also used to manage conditions such as type 2 diabetes, and some have demonstrated cardiovascular or kidney benefits in specific groups. - Do GLP-1 medications cause weight loss?
They can. By reducing appetite, increasing feelings of fullness, and slowing stomach emptying, they can help some people lose a significant amount of weight. - What are the most common side effects?
Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort are among the most common side effects, particularly when starting treatment or increasing the dose. - Will I regain weight if I stop taking a GLP-1 medication?
Weight regain is common after stopping treatment, although the amount varies between individuals. This is why stopping treatment should ideally be discussed with a healthcare professional. - Can I take GLP-1 medications during pregnancy?
GLP-1 medications are generally not recommended during pregnancy. Anyone who is pregnant or planning a pregnancy should speak to their healthcare professional about their specific medication and when it should be stopped. - Are GLP-1 medications safe for everyone?
No. Suitability depends on your medical history, other medications, and individual circumstances. They should only be used under appropriate medical supervision. - Are online or compounded GLP-1 medications safe?
Unapproved products can carry additional risks, including problems with quality and dosing. It is safest to obtain these medications through a legitimate healthcare professional and pharmacy. - Are GLP-1 medications a quick fix?
No. They are medical treatments that work alongside broader approaches to health, including nutrition, physical activity, and long-term medical care. For some people, ongoing treatment may be needed to maintain the benefits.
References
About the Author
Celine Abdallah
Founder